Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3200-2026

Howmedica Osteonics Corp. recalls DURACON XL ANGLED TIB INS 11/14MM C-M064-1-300 SELF-PRESSURIZING GLENOID SIZE 8…

Howmedica Osteonics Corp.Mahwah, NJ, United StatesReported Sep 23, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in increased wear, leading to hazards such as excessive wear debris, material fragments, fractured device, or disassociated device. Potential harms include revision surgery, pain, and inflammation.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • DURACON XL ANGLED TIB INS 11/14MM C-M064-1-300 SELF-PRESSURIZING GLENOID SIZE 8 C-M062-6-800 C-M062-7-500 C-M063-2-600 SELF-PRESSURIZING GLENOID SIZE 9 C-M063-5-000 SHOULDER - GLENOID #11 5361-6111 SHOULDER - GLENOID #5 5361-6105 SHOULDER - GLENOID #7 5361-6107 SHOULDER - GLENOID #9 5361-6109 SHOULDER - KEELED GLENOID #11 5361-6211 SHOULDER - KEELED GLENOID #5 5361-6205 SHOULDER - KEELED GLENOID #7 5361-6207 SHOULDER - KEELED GLENOID #9 5361-6209 Orthopaedic implant components manufactured from UHMWPE (polyethylene)C-M064-1
    UDI-DI 07613327138191UDI Lots
    130 affected lots
    RX06413AC-M062-6-800RX06268AC-M062-7-500RX06275AC-M063-2-600RX06326AC-M063-5-000
    +122 moreRX06350ARX06350AA5361-611107613327138191AFZT00UAFZT00ZP2N04BP3K57P3K57BP3K57FPYE43BPZA70FPZA70U5361-610507613327138214AF2S09UAF2S09ZP1H41P4T02P4T02X1P4T02X2P4T02X3P4T02X4P4T02X5P4T02X65361-610707613327138207AF3E00AF3E00BAF3E00FAF3E00GAF3E00QAF3E00SP4A238P4A238X1P4A238X2P4A238X3P4A238X4P4A238X5P4A238X6P4A238X7P4A238X8P4L09P4L09X1P4L09X10P4L09X2P4L09X3P4L09X4P4L09X5P4L09X6P4L09X7P4L09X8P4L09X9P4N06P4N06X1P4N06X2P4N06X3P4N06X4P4N06X5P4N06X6P4N06X7P4T03P4T03X1P4T03X2P4T03X3P4T03X4P4T03X5P4T03X6P4T03X7P4T03X8P4V01P4V01X1P4V01X2P4V01X3P4V01X4P4V01X5P4V01X6P4V01X7P4V01X85361-610907613327138153AF3E02IAF3E02SAF3E02ZP1H39Q5361-621107613327138283AFZS09FAFZS09GAFZS09SP2N08PYC30X1PYW24X1PZKDHX15361-6205076133271381771NMMPE1NNMPEP3K58P3K58BP3K58F5361-620707613327138269AF2S10BAF2S10FAF2S10GP4A241P4A241X1P4A241X2P4A241X3P4V03P4V03X1P4V03X2P4V03X3P4V03X4P4V03X5PZKDFX15361-620907613327138238AF2K03ZAFZS10SAFZS10U

What the firm is doing

Firm began notifying customers on July 30, 2026, via FedEx 2-day air. Customers were instructed to quarantine and discontinue use of the affected product. Affected product should be returned to the firm.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of Canada, LATAM, Europe, Asia Pacific, and South Africa.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls